HPGC Renmintongtai Pharmaceutical Corporation (SHA:600829)
China flag China · Delayed Price · Currency is CNY
8.71
+0.10 (1.16%)
Oct 23, 2026, 3:00 PM CST

SHA:600829 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
158.58133.84213.27292.16264.48277.3
Depreciation & Amortization
57.4257.4261.5460.1863.9960.44
Other Amortization
5.625.623.535.924.54.33
Loss (Gain) From Sale of Assets
0.440.44-0.230.350.36-0.07
Asset Writedown & Restructuring Costs
2.262.262.150.810.31.95
Loss (Gain) From Sale of Investments
---13.9-3.89--
Provision & Write-off of Bad Debts
59.9759.9719.2424.85-11.089.17
Other Operating Activities
-117.124.2228.2227.0227.0117.82
Change in Accounts Receivable
163.19163.19-10.6-228.880.7-292.96
Change in Inventory
-129.47-129.4716.45-41.4131.2217.35
Change in Accounts Payable
-1.15-1.15-204.15201.01-76.03-326.39
Operating Cash Flow
183.4299.98115.44332.99307.33-233
Operating Cash Flow Growth
309.44%159.86%-65.33%8.35%--

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-28.33-17.16-8.04-23.48-6.42-12.24
Sale of Property, Plant & Equipment
0.10.130.150.260.550.69
Other Investing Activities
----156.64--
Investing Cash Flow
-28.23-17.02-7.89-179.86-5.87-11.55

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-790949.22681.731,3921,320
Total Debt Issued
804.4790949.22681.731,3921,320
Short-Term Debt Repaid
--840.6-1,072-917.8-1,299-699
Long-Term Debt Repaid
--42.5-42.19-46.42-42.75-44.93
Lease Payments
-42.5-42.5-42.19-46.42-42.75-44.93
Total Debt Repaid
-892.5-883.1-1,114-964.22-1,342-743.93
Net Debt Issued (Repaid)
-88.1-93.1-165.05-282.4950.12575.74
Common Dividends Paid
-17.61-20.08-160.41-24.62-30.48-35.65
Other Financing Activities
-5.45--424.97129.88-197.78
Financing Cash Flow
-111.16-113.18-325.46117.86149.51342.31

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
44.01169.78-217.92270.99450.9797.76

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
155.06282.82107.39309.5300.91-245.24
Free Cash Flow Growth
382.32%163.34%-65.30%2.85%--
Free Cash Flow Margin
1.46%2.73%1.07%2.98%3.12%-2.63%
Free Cash Flow Per Share
0.270.490.180.530.52-0.42
Levered Free Cash Flow
132.89347.5-16.7366.86406.36-152
Unlevered Free Cash Flow
147.76362.810.98383.88434.13-120.55
Free Cash Flow After Leases
112.57240.3265.2263.08258.16-290.17

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
293.97256.61305.32281.41254.71281.28
Change in Working Capital
16.216.2-198.39-74.41-42.23-603.92